Does Chamomile Sleep Randomized Trial work?

Updated July 2026

Quick Answer

Chamomile Sleep Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Background Aromatherapy has been proposed as a non-pharmacological adjunctive intervention in critical care settings; however, evidence regarding its effects on objective outcome measures remains inconclusive.

Key Takeaways

  • 01Background Aromatherapy has been proposed as a non-pharmacological adjunctive intervention in critical care settings; however, evidence regarding its effects on objective outcome measures remains inconclusive. [Moyano PA (2026)]
  • 02Contrary to our hypothesis, no studies measured biochemical stress markers such as cortisol or catecholamines, representing a significant gap in the evidence base. [Moyano PA (2026)]
  • 03A notable finding was the disparity between evidence certainty: high for anxiety reduction versus low/very low for physiological outcomes, highlighting inadequate control for ICU-specific confounders in existing trials. [Moyano PA (2026)]
  • 04This systematic review aimed to evaluate the effectiveness of aromatherapy in modulating objective physiological and biochemical markers in adult intensive care unit (ICU) patients. [Moyano PA (2026)]
The current Migaku evidence database contains 2 reusable source documents for Chamomile Sleep Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove. - Background Aromatherapy has been proposed as a non-pharmacological adjunctive intervention in critical care settings; however, evidence regarding its effects on objective outcome measures remains inconclusive. [Moyano PA (2026); evidence level 1] - Contrary to our hypothesis, no studies measured biochemical stress markers such as cortisol or catecholamines, representing a significant gap in the evidence base. [Moyano PA (2026); evidence level 1] - A notable finding was the disparity between evidence certainty: high for anxiety reduction versus low/very low for physiological outcomes, highlighting inadequate control for ICU-specific confounders in existing trials. [Moyano PA (2026); evidence level 1] - This systematic review aimed to evaluate the effectiveness of aromatherapy in modulating objective physiological and biochemical markers in adult intensive care unit (ICU) patients. [Moyano PA (2026); evidence level 1] - Failure to meet the recommended 7-9 hours of restful sleep per night is known to increase the risk of several health conditions, reason why regular and adequate sleep should be seen as a priority instead of an unnecessary commodity easily traded as required by the commitments of our busy lives. [Conti F (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Effects of aromatherapy on objective physiological outcomes in adult ICU patients: a systematic review.
  2. Dietary Protocols to Promote and Improve Restful Sleep: A Narrative Review.